ArticleObesity surgery2025
Short-term weight loss and metabolic outcomes after LSG and LRYGB in Chinese patients: a propensity score-matched retrospective analysis.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsTo compare weight loss and metabolic parameters changes between laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-gastric bypass (LRYGB) in obese patients. MATERIALS AND
methodsThis retrospective study included 824 patients treated with LSG or LRYGB between January 2014 and August 2022 at the First Affiliated Hospital of Jinan University. A 1:1 propensity score matching method was used to compare the LSG and LRYGB groups. Differences in weight loss outcomes, changes in biochemical levels, and differences in nutritional status at 6- and 12- months postoperatively were assessed in different Chinese populations.
resultsLSG and LRYGB groups each comprised 412 patients. The baseline characteristics of the two groups showed no significant differences. However, patients with type 2 diabetes mellitus (T2DM) who underwent LRYGB exhibited significantly reduced glycated hemoglobin (HbA1c) levels compared to those who had LSG after the 12-month postoperative follow-up. Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) levels are reduced in patients with nonalcoholic fatty liver disease (NAFLD). Alcohol consumption was shown to adversely affect surgical outcomes, with a notable association observed in postoperative weight regain. Females had lower body mass index (BMI) and blood glucose levels 6 months after LSG and lower BMI and blood pressure levels 12 months after LRYGB. Bariatric surgery caused severe nutritional deficiencies, notably affecting vitamin D levels, with over 60% of patients in both groups experiencing insufficiency postoperatively.
conclusionsBoth LSG and LRYGB surgeries were determined to be safe and efficacious. LSG proved particularly beneficial for patients with NAFLD, while LRYGB was more efficacious for those with T2DM, hypercholesterolemia, and hypertensive women.
Indexed as
Identifiers
41085911What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.